| pubmed-article:18342917 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18342917 | lifeskim:mentions | umls-concept:C1516213 | lld:lifeskim |
| pubmed-article:18342917 | lifeskim:mentions | umls-concept:C0009247 | lld:lifeskim |
| pubmed-article:18342917 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:18342917 | lifeskim:mentions | umls-concept:C0009488 | lld:lifeskim |
| pubmed-article:18342917 | lifeskim:mentions | umls-concept:C0038952 | lld:lifeskim |
| pubmed-article:18342917 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:18342917 | pubmed:dateCreated | 2008-12-1 | lld:pubmed |
| pubmed-article:18342917 | pubmed:abstractText | The existence of comorbid diseases among men with newly diagnosed prostate cancer may affect prostate cancer prognosis. | lld:pubmed |
| pubmed-article:18342917 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18342917 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18342917 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18342917 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18342917 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:18342917 | pubmed:issn | 1527-9995 | lld:pubmed |
| pubmed-article:18342917 | pubmed:author | pubmed-author:RoyI LIL | lld:pubmed |
| pubmed-article:18342917 | pubmed:author | pubmed-author:SørensenHenri... | lld:pubmed |
| pubmed-article:18342917 | pubmed:author | pubmed-author:BorreMichaelM | lld:pubmed |
| pubmed-article:18342917 | pubmed:author | pubmed-author:NørgaardMette... | lld:pubmed |
| pubmed-article:18342917 | pubmed:author | pubmed-author:JacobsenJacob... | lld:pubmed |
| pubmed-article:18342917 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18342917 | pubmed:volume | 72 | lld:pubmed |
| pubmed-article:18342917 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18342917 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18342917 | pubmed:pagination | 1258-62 | lld:pubmed |
| pubmed-article:18342917 | pubmed:meshHeading | pubmed-meshheading:18342917... | lld:pubmed |
| pubmed-article:18342917 | pubmed:meshHeading | pubmed-meshheading:18342917... | lld:pubmed |
| pubmed-article:18342917 | pubmed:meshHeading | pubmed-meshheading:18342917... | lld:pubmed |
| pubmed-article:18342917 | pubmed:meshHeading | pubmed-meshheading:18342917... | lld:pubmed |
| pubmed-article:18342917 | pubmed:meshHeading | pubmed-meshheading:18342917... | lld:pubmed |
| pubmed-article:18342917 | pubmed:meshHeading | pubmed-meshheading:18342917... | lld:pubmed |
| pubmed-article:18342917 | pubmed:meshHeading | pubmed-meshheading:18342917... | lld:pubmed |
| pubmed-article:18342917 | pubmed:meshHeading | pubmed-meshheading:18342917... | lld:pubmed |
| pubmed-article:18342917 | pubmed:meshHeading | pubmed-meshheading:18342917... | lld:pubmed |
| pubmed-article:18342917 | pubmed:meshHeading | pubmed-meshheading:18342917... | lld:pubmed |
| pubmed-article:18342917 | pubmed:meshHeading | pubmed-meshheading:18342917... | lld:pubmed |
| pubmed-article:18342917 | pubmed:meshHeading | pubmed-meshheading:18342917... | lld:pubmed |
| pubmed-article:18342917 | pubmed:meshHeading | pubmed-meshheading:18342917... | lld:pubmed |
| pubmed-article:18342917 | pubmed:meshHeading | pubmed-meshheading:18342917... | lld:pubmed |
| pubmed-article:18342917 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18342917 | pubmed:articleTitle | Impact of comorbidity on survival of Danish prostate cancer patients, 1995-2006: a population-based cohort study. | lld:pubmed |
| pubmed-article:18342917 | pubmed:affiliation | Department of Urology, Viborg Hospital, Viborg, Denmark. dr.ll@dadlnet.dk | lld:pubmed |
| pubmed-article:18342917 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18342917 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
